Tag: Antibody Drug Conjugates
Antibody drug conjugates market is projected to grow at an annualized rate of over 20%, till 2030
Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers
0
0
0
4 May, 04:15 AM
Asia Pacific Is Expected To Witness Significant Growth In The Global Over The Forecast Period
The difficulties involved in the production of ADCs act as a restraint on the antibody drug conjugates market.
0
0
0
29 Nov, 10:35 AM
